Mr. Martell previously served as CEO at Poniard Pharmaceuticals. Earlier, he worked at Imclone Systems, where he led the launch and initial commercialization of oncology drug Erbitux. Mr. Martell has also worked at Genentech, where he led the commercial launch of cancer drugs Rituxan and Herceptin.
Sign up for our FREE Pain E-Weekly for more coverage like this sent to your inbox!
Related Articles on Pain Management:
5 Changes for Outpatient Anesthesia in 2012: Thoughts From Dr. Gilbert Drozdow
New Maryland Surgery Center to Include Pain Management
16 New Pain Management Facility Openings in 2011
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
